Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04547504
What this trial is testing

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

Who this might be right for
Non-small-cell Lung Cancer
University Hospital, Brest 349
Testing effectiveness (Phase 2)Study completedNCT00636610
What this trial is testing

Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 199
Post-approval studies (Phase 4)Ended earlyNCT04819360
What this trial is testing

Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis

Who this might be right for
Urinary Bladder, NeurogenicMultiple Sclerosis
Brigitte Schürch 1
Post-approval studies (Phase 4)UnknownNCT04554524
What this trial is testing

Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma

Who this might be right for
Thymoma and Thymic Carcinoma
Tang-Du Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT07544784
What this trial is testing

AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)
Fudan University 73
Testing effectiveness (Phase 2)Looking for participantsNCT04689347
What this trial is testing

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 27
Not applicableStudy completedNCT03417349
What this trial is testing

Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke

Who this might be right for
Cerebrovascular StrokeStroke, AcuteCerebral Stroke
Dr. Markus Alfred Möhlenbruch 250
Testing effectiveness (Phase 2)UnknownNCT03271255
What this trial is testing

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Who this might be right for
Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal Neoplasms+1 more
Shenzhen People's Hospital 80
Post-approval studies (Phase 4)Study completedNCT03321955
What this trial is testing

Ziconotide as First-Line IDT

Who this might be right for
Neuropathic Pain
Albany Medical College 13
Not applicableUnknownNCT04042415
What this trial is testing

Calorie Restriction in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingCaloric Restriction
Federico II University 93
Not applicableNot Yet RecruitingNCT06904547
What this trial is testing

Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC

Who this might be right for
ALK-Positive NSCLC
Shanghai Chest Hospital 100
Large-scale testing (Phase 3)UnknownNCT03402048
What this trial is testing

The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial

Who this might be right for
Stage IV, NSCLCLung NeoplasmsBronchial Neoplasms+6 more
University of Turin, Italy 567
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06908733
What this trial is testing

Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)
Liaoning Cancer Hospital & Institute 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03425838
What this trial is testing

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Who this might be right for
Breast Neoplasm Female
Borstkanker Onderzoek Groep 1,050
Testing effectiveness (Phase 2)Study completedNCT04188847
What this trial is testing

First-line Chemotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 37
Large-scale testing (Phase 3)Study completedNCT01382147
What this trial is testing

Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Prof. Dr. Wolfgang Hiddemann 396
Large-scale testing (Phase 3)Study completedNCT05629949
What this trial is testing

A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Qilu Pharmaceutical Co., Ltd. 474
Post-approval studies (Phase 4)Looking for participantsNCT03500133
What this trial is testing

Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.

Who this might be right for
Pediatric Hodgkin's Disease
Hospital JP Garrahan 500
Not applicableStudy completedNCT05858749
What this trial is testing

Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 494
Post-approval studies (Phase 4)Study completedNCT00461149
What this trial is testing

Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly

Who this might be right for
Acromegaly
Federico II University 50
Next Page